Homatropine
DISCONTINUED
The Isopto Homatropine brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
| Homatropine | |
|---|---|
| DOSAGE | 1 or 2 gtts for cycloplegia |
| Anterior Uveitis Treatment (Mild/Moderate) | Anterior Uveitis Treatment (Severe) |
| (1) Cyclopentolate 1% TID (2) PF 1% or Durzol 0.5% q1-6hrs, depending on severity, then taper QID x 1 week, TID x 1 week, then BID x 1 week. D/c when there is no AC reaction | (1) Atropine 1% BID to QID (2) PF 1% or Durzol 0.5% q1-2 hours initial, consider a loading dosage q1min for 5 mins x 2 weeks, then taper QID x 1 week, TID x 1 week, then BID x 1 week. D/c when there is no AC reaction |
| GENERIC | Homatropine Hydrobromide ophthalmic soln 2% and 5% |
| SIZE | 5mL |
| INDICATIONS | Cycloplegia, Mydriasis, Uveitis |
| MECHANISM OF ACTION | Anticholinergic agent |
| MICROBIOLOGY | By blocking acetylcholine it prevents the iris sphincter from constricting and the ciliary muscles from accommodating |
| CONTRAINDICATIONS & WARNINGS | Contraindicated in patients with narrow angles or hypersensitivity to ingredients |
| PEDIATRIC USE | Homatropine should not be used during the first three months of life due to a possible association between the cycloplegia produced and the development of amblyopia. |
| PREGNANCY | Category C |
| NOTE | Cyclopentolate 1% TID or Atropine 1% BID to QID instead |